These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30386602)

  • 21. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease.
    Savarino E; Marabotto E; Zentilin P; Frazzoni M; Sammito G; Bonfanti D; Sconfienza L; Assandri L; Gemignani L; Malesci A; Savarino V
    Dig Liver Dis; 2011 Jul; 43(7):542-7. PubMed ID: 21376679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease.
    Becher A; El-Serag H
    Aliment Pharmacol Ther; 2011 Sep; 34(6):618-27. PubMed ID: 21770991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors.
    Koek GH; Sifrim D; Lerut T; Janssens J; Tack J
    Gut; 2003 Oct; 52(10):1397-402. PubMed ID: 12970129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TOPPITS: Trial Of Proton Pump Inhibitors in Throat Symptoms. Study protocol for a randomised controlled trial.
    Watson G; O'Hara J; Carding P; Lecouturier J; Stocken D; Fouweather T; Wilson J
    Trials; 2016 Apr; 17():175. PubMed ID: 27036555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oesophageal motility defects associated with nocturnal gastro-oesophageal reflux on proton pump inhibitors.
    Fouad YM; Katz PO; Castell DO
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1467-71. PubMed ID: 10571603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease.
    Prakash C; Clouse RE
    Clin Gastroenterol Hepatol; 2005 Apr; 3(4):329-34. PubMed ID: 15822037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent gastro-oesophageal reflux symptoms despite proton pump inhibitor therapy.
    Ang D; How CH; Ang TL
    Singapore Med J; 2016 Oct; 57(10):546-551. PubMed ID: 27779277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use.
    Klok RM; Postma MJ; van Hout BA; Brouwers JR
    Aliment Pharmacol Ther; 2003 May; 17(10):1237-45. PubMed ID: 12755837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton pump inhibitors for the treatment of laryngopharyngeal reflux disease: A protocol for systematic review and meta-analysis.
    Liu X; Jiang Y; Luo H; Liu H
    Medicine (Baltimore); 2020 Dec; 99(49):e23297. PubMed ID: 33285706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On-demand proton pump inhibitor therapy in patients with gastro-oesophageal reflux disease.
    Pace F; Pallotta S; Bianchi Porro G
    Dig Liver Dis; 2002 Dec; 34(12):870-7. PubMed ID: 12643297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease.
    Gunaratnam NT; Jessup TP; Inadomi J; Lascewski DP
    Aliment Pharmacol Ther; 2006 May; 23(10):1473-7. PubMed ID: 16669962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
    Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
    Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11).
    Lacy BE; Chehade R; Crowell MD
    Am J Gastroenterol; 2011 Sep; 106(9):1604-11. PubMed ID: 21691342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients.
    Zacny J; Zamakhshary M; Sketris I; Veldhuyzen van Zanten S
    Aliment Pharmacol Ther; 2005 Jun; 21(11):1299-312. PubMed ID: 15932360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ambulatory Reflux Monitoring Guides Proton Pump Inhibitor Discontinuation in Patients With Gastroesophageal Reflux Symptoms: A Clinical Trial.
    Yadlapati R; Masihi M; Gyawali CP; Carlson DA; Kahrilas PJ; Nix BD; Jain A; Triggs JR; Vaezi MF; Kia L; Kaizer A; Pandolfino JE
    Gastroenterology; 2021 Jan; 160(1):174-182.e1. PubMed ID: 32949568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring.
    Mainie I; Tutuian R; Shay S; Vela M; Zhang X; Sifrim D; Castell DO
    Gut; 2006 Oct; 55(10):1398-402. PubMed ID: 16556669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.